Translate
Pharmather Holdings Ltd
About
Pharmather Holdings Ltd (CN:PHRM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology
Mar 26 2026
PharmaTher Introduces PatchPrint(TM) With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches
Mar 3 2026
PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market
Feb 2 2026
PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success
Jan 14 2026
PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs
Recent Videos
![No More Needles!? Painless "Patch" Medicine is Changing the Future! [Latest Patent Tech] #Shorts](https://i.ytimg.com/vi/tLAZWWZp2YE/hqdefault.jpg)
No More Needles!? Painless "Patch" Medicine is Changing the Future! [Latest Patent Tech] #Shorts
Apr 19, 2026
Peptide Research: The $160B Revolution & Needle-Free Future
Mar 06, 2026
Peptide Research: The $160B Revolution & Needle-Free Future
Mar 06, 2026
FDA Approves KETARx (ketamine) for Surgical Pain Management
Jan 01, 2026
Financials
Revenue
CA$0
Market Cap
CA$5.92 M
EPS
-0.02
